author-photo

Ann Johnson

Genentech

6

Papers

80

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Real-world treatment patterns in stages IA-IIIB non-small cell lung cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Artificial intelligence (AI)–powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Real-world evidence of cancer immunotherapy (CIT) combination treatment in first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (77)